AMSTERDAM, December 17, 2013 /PRNewswire/ --
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that it will flip seven established subscription journals to a gold open access model starting from 1st January 2014.
These titles include Physics Letters B and Nuclear PhysicsB as part of Elsevier's participation in the SCOAP (Sponsoring Consortium for Open Access Publishing in Particle Physics) initiative. Other titles include Stem Cell Research, The International Journal of Infectious Diseases , Developmental Cognitive Neuroscience, Epidemics and EJC Supplements.
"This announcement is part of Elsevier's ongoing effort to help facilitate further implementation of open access options," said Philippe Terheggen, Managing Director of STM journals at Elsevier. "In areas where we have seen a clear uptake and support for open access publishing from authors, funders and the wider community we have made the decision to flip the journal. Our priority is always to focus on what authors need and to provide the best quality journal which will serve the community regardless of the business model."Journals that are changed from subscription-based to open access will retain the same editorial standards and instead of through subscriptions, the publication costs of the journals will be covered through an article processing fees paid by the authors or, in the case of Physics Letters B and Nuclear Physics B, by the SCOAP3 consortium. Libraries will no longer need to subscribe to these titles, and past issues remain accessible to subscribers through their collection agreements. "As high-energy physics journals flip to open access, this is a time of reflection," said Salvatore Mele, who led the development of the SCOAP3 initiative at CERN. "Hard work and close collaboration have brought this open access initiative into reality. Many different stakeholders have reached unprecedented consensus: libraries, funding agencies, research organizations and publishers such as Elsevier. All together they have made this possible." About Open Access Publishing at Elsevier
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts